Most Popular Stories
- UnitedHealth Group's Stephen Hemsley - CEO Compensation
- Proposed cosmetic surgery tax is wrinkling a few brows
- Senate releases $848 billion health reform bill
- Study: Current EMRs don't have measurable impact on cost or quality
- AMIA 09: CHCF president calls for more 'Kaiserness' to connect information
- Study: Physicians missing kidney disease diagnoses
Featured Jobs
-
Director of Infection Control Job in VA
StaffPointe, LLC - central, VA -
Med/Surg Oncology RN Job in New York
StaffPointe, LLC - near Plattsburgh, NY -
Family Practice Job in Indiana
StaffPointe, LLC - near Lawrenceburg, IN -
RN First Assist Job in Tennessee
StaffPointe, LLC - central, TN -
Dermatologist Job in Arkansas
StaffPointe, LLC - northwest, AR
Events
- Harvard Business School 7th Healthcare Conference
January 30, 2010 - Security Audits: Is Your Organization Prepared and In Compliance?
Dec.3 at 12 pm CT
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
FEATURES >> YouTube | Top acute-care hospitals | Women in Health IT | Top BlackBerry Apps | Commentary
TOPICS >> Stimulus | Health Reform | CMS News | Finance | EMRs | Mobile Healthcare | Hospital Leadership Blog
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Electronic Medical Records (EMRs)
- Food and Drug Administration (FDA)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- prescription drugs
- health reform
- pharmaceutical companies
ALSO NOTED: AIDS vaccine back at square one; What's behind the FDA's low drug approval rating?; and much more...
> After trying and failing repeatedly to develop an AIDS vaccine, federal officials say they're going back to the drawing board to come up with some new ideas. Report
> Could hip and knee doctors be receiving kickbacks from orthopedic device companies? According to the New York Times, a federal investigation on kickbacks in the orthopedic industry is pointing in the direction of doctors who "receive money as the [orthopedic device] companies' paid consultants." Report
> Although current executives at Emerson Hospital deny any wrongdoing, it certainly looks as if two former executives at the Concord, MA facility were found to have created misleading financial documents. Report
> Is a rising tide of risk aversion at a post-Vioxx FDA behind the agency's anemic approval record? No way, say the FDA's Janet Woodcock. Report
> A hospital looking for a new home doesn't seem to be offering enough compensation to people for theirs. Report
> If you're looking to get high, why not go for a run? Article
And Finally... Dr. Andrew Wakefield and two colleagues will begin their defense today against charges they violated ethics guidelines in the U.K. while developing a 1998 paper that linked autism to vaccines. That study raised a hue and cry around the world that has yet to completely die down, even after a raft of studies now conclude that there is no link. Report
Related Stories
- FDA under fire for $1.5 million morale-boosting contract
- Merck agrees to $58M settlement on Vioxx ads
- Reports suggest that Merck downplayed Vioxx risks
- WellPoint, FDA collaborate on tracking drug safety
- Bill giving FDA more drug safety powers could pass
- Drugmakers face direct-to-consumer ad ban
- SPOTLIGHT: Outsiders should see FDA safety data
- Despite risks, Pfizer seeks Celebrex use for kids
- Gilmartin testifies in Vioxx suit
- Topol's demotion raises issues
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map | List in Marketplace | Supplier MarketplaceTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |





